SAN DIEGO, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Aardvark Therapeutics, Inc. (Aardvark) (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on…
ROCKVILLE, MD, Nov. 25, 2025 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing innovative antibody-based therapeutics…
PHILADELPHIA, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Century Therapeutics, Inc. (‘Century’, NASDAQ: IPSC), a biotechnology company developing induced pluripotent stem…
DAEJEON, South Korea, Nov. 26, 2025 /PRNewswire/ -- Korea Innovation Foundation (INNOPOLIS), currently operating the 2025 Global Technology Commercialization Support…
TÜBINGEN, DE AND BOSTON, MA / ACCESS Newswire / November 25, 2025 / CureVac N.V. (Nasdaq:CVAC)(CureVac or the Company), a…
ST. PAUL, Minn., Nov. 25, 2025 /PRNewswire/ -- Solventum (NYSE: SOLV) announced today that management will participate in a fireside chat…
FARMINGTON HILLS, Mich., Nov. 25, 2025 /PRNewswire/ -- The end of the year is just around the corner, which means…
Strategic partnership brings a dental-optimized, medical-grade EHR platform to dental education, supporting whole-person care and advancing dental-medical integrationHENDERSON, Nev., Nov.…
VANCOUVER, BC / ACCESS Newswire / November 25, 2025 / Onco-Innovations Limited (CBOE CA:ONCO)(Frankfurt:W1H, WKN:A3EKSZ)(OTCQB:ONNVF) ("Onco" or the "Company") is…
AUSTIN, TX / ACCESS Newswire / November 25, 2025 / Struggling to solve different health issues at the same time,…